Normal Healthy Subjects
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Halia TherapeuticsHT-4253
Halia TherapeuticsHT-6184
Clinical Trials (2)
Total enrollment: 144 patients across 2 trials
Study to Evaluate HT-4253 in Healthy Subjects
Start: Sep 2024Est. completion: May 202580 patients
Phase 1Completed
Study to Evaluate HT-6184 in Healthy Subjects
Start: Jun 2022Est. completion: Jul 202364 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.